Brain Health
FDA Approves First Drug for Hunter Syndrome Brain Complications in Children
Avlayah becomes the first treatment targeting neurologic symptoms of rare genetic disorder affecting 500 Americans.
Drug Approval
Apr 15, 2026 0
Results for "Clonal Hematopoiesis" in Alzheimer's
7 articles
Brain Health
FDA Approves First Drug to Treat Neurologic Complications of Hunter Syndrome
Avlayah (tividenofusp alfa-eknm) becomes the first therapy approved to address brain damage in Hunter syndrome, a rare pediatric disorder.
Drug Approval
Apr 28, 2026 0
Brain Health
FDA Approves First Treatments for Rare Neurological Conditions
Two breakthrough approvals target Hunter syndrome brain complications and cerebral folate deficiency for the first time.
Drug Approval
Apr 7, 2026 0
Brain Health
FDA Approves Leucovorin for Cerebral Folate Deficiency Caused by FOLR1 Variants
Wellcovorin becomes the first approved treatment for cerebral folate deficiency tied to FOLR1 gene variants, offering hope for a rare neurological condition.
Drug Approval
May 31, 2026 0
Brain Health
FDA Approves Four Neurological Drugs Targeting Alzheimer's, Glioma, and Rare Disease
A roundup of recent FDA brain-health approvals including lecanemab's full Alzheimer's approval and a new glioma drug.
Drug Approval
May 5, 2026 0
Brain Health
Four Neurology Drug Approvals Reshaping Brain Disease Treatment
From Alzheimer's to Parkinson's, a wave of novel FDA approvals is expanding treatment options for serious neurological conditions.
Drug Approval
May 8, 2026 0
Brain Health
Spinraza Gets Higher-Dose Approval to Boost Brain Fluid Exposure in SMA
FDA approves an updated Spinraza regimen for spinal muscular atrophy, targeting improved CSF drug levels for better neurological outcomes.
Drug Approval
Apr 26, 2026 0